The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
Horizon: Validation of an improved method for rapid characterization of protein aggregates in biologic drugs for increased quality and safetySBC: OPTOFLUIDICS, INC. Topic: NA
Optofluidics and the University of Delaware propose to complete the development of the Horizon technology and carry out validation via a comprehensive multi-site study. The technology is a subvisible particle analyzer pioneered during Phase I. The technology is designed to fill two critical gaps in biopharmaceutical product development: (1) Scientists can count and image particles with current too ...SBIR Phase II 2017 Department of CommerceNational Institute of Standards and Technology
SBC: Innovative Tech. Solutions Topic: N/A
N/ASBIR Phase I 1995 Nuclear Regulatory Commission